|
1
|
Mosier SM, Patel T, Strenge K and Mosier
AD: Chondrosarcoma in childhood: the radiologic and clinical
conundrum. J Radiol Case Rep. 6:32–42. 2012.
|
|
2
|
Logie CI, Walker EA, Forsberg JA, Potter
BK and Murphey MD: Chondrosarcoma: A diagnostic imager’s guide to
decision making and patient management. Semin Musculoskelet Radiol.
17:101–115. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Raederstorff D, Kunz I and Schwager J:
Resveratrol, from experimental data to nutritional evidence: the
emergence of a new food ingredient. Ann N Y Acad Sci. 1290:136–141.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Borriello A, Bencivenga D, Caldarelli I,
et al: Resveratrol: from basic studies to bedside. Cancer Treat
Res. 159:167–184. 2014.
|
|
5
|
Widlund AL, Baur JA and Vang O: mTOR: more
targets of resveratrol? Expert Rev Mol Med. 15:e102013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Singh CK, George J and Ahmad N:
Resveratrol-based combinatorial strategies for cancer management.
Ann N Y Acad Sci. 290:113–121. 2013. View Article : Google Scholar
|
|
7
|
Yang Q, Wang B, Zang W, et al: Resveratrol
inhibits the growth of gastric cancer by inducing G1 phase arrest
and senescence in a Sirt1-dependent manner. PLoS One. 8:e706272013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gweon EJ and Kim SJ: Resveratrol
attenuates matrix metal-loproteinase-9 and -2-regulated
differentiation of HTB94 chondrosarcoma cells through the p38
kinase and JNK pathways. Oncol Rep. 32:71–78. 2014.PubMed/NCBI
|
|
9
|
Im HJ, Li X, Chen D, et al: Biological
effects of the plant-derived polyphenol resveratrol in human
articular cartilage and chondrosarcoma cells. J Cell Physiol.
227:3488–3497. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siegfried Z, Bonomi S, Ghigna C and Karni
R: Regulation of the Ras-MAPK and PI3K-mTOR signalling pathways by
alternative splicing in cancer. Int J Cell Biol. 2013:5689312013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cantley LC: The phosphoinositide 3-kinase
pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu YZ, Wu K, Huang J, et al: The
PTEN/PI3K/AKT and Wnt/β-catenin signaling pathways are involved in
the inhibitory effect of resveratrol on human colon cancer cell
proliferation. Int J Oncol. 45:104–112. 2014.PubMed/NCBI
|
|
13
|
Sui T, Ma L, Bai X, Li Q and Xu X:
Resveratrol inhibits the phosphatidylinositide 3-kinase/protein
kinase B/mammalian target of rapamycin signaling pathway in the
human chronic myeloid leukemia K562 cell line. Oncol Lett.
7:2093–2098. 2014.PubMed/NCBI
|
|
14
|
Shan Z, Yang G, Xiang W, Pei-jun W and Bin
Z: Effects of resve-ratrol on oral squamous cell carcinoma (OSCC)
cells in vitro. J Cancer Res Clin Oncol. 140:371–374. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ji Q, Liu X, Fu X, et al: Resveratrol
inhibits invasion and metastasis of colorectal cancer cells via
MALAT1 mediated Wnt/β-catenin signal pathway. PLoS One.
8:e787002013. View Article : Google Scholar
|
|
16
|
Poincloux R, Lizárraga F and Chavrier P:
Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to
invadopodia. J Cell Sci. 122:3015–3024. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Turpeenniemi-Hujanen T: Gelatinases (MMP-2
and -9) and their natural inhibitors as prognostic indicators in
solid cancers. Biochimie. 87:287–297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gweon EJ and Kim SJ: Resveratrol induces
MMP-9 and cell migration via the p38 kinase and PI-3 K pathways in
HT1080 human fibrosarcoma cells. Oncol Rep. 29:826–834. 2013.
|
|
19
|
Li W, Ma J, Ma Q, et al: Resveratrol
inhibits the epithelial-mesenchymal transition of pancreatic cancer
cells via suppression of the PI-3K/AKT/NF-κB pathway. Curr Med
Chem. 20:4185–4194. 2013. View Article : Google Scholar
|
|
20
|
Pei Y, Harvey A, Yu XP, Chandrasekhar S
and Thirunavukkarasu K: Differential regulation of cytokine-induced
MMP-1 and MMP-13 expression by p38 kinase inhibitors in human
chondrosarcoma cells: potential role of Runx2 in mediating p38
effects. Osteoarthritis Cartilage. 14:749–758. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
El-Mowafy AM and White RE: Resveratrol
inhibits MAPK activity and nuclear translocation in coronary artery
smooth muscle: reversal of endothelin-1 stimulatory effects. FEBS
Lett. 451:63–67. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
George J, Singh M, Srivastava AK, et al:
Resveratrol and black tea polyphenol combination synergistically
suppress mouse skin tumors growth by inhibition of activated MAPKs
and p53. PLoS One. 6:e233952011. View Article : Google Scholar : PubMed/NCBI
|
